NCT07172997View on ClinicalTrials.gov

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Active, not recruitingOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
MASLDT2DM (Type 2 Diabetes Mellitus)Non-alcoholic Fatty Liver Disease (NAFLD)Obesity
Interventions
PROCEDURE

Bariatric Surgery

A surgical procedure used to manage obesity and obesity-related conditions.

Trial Locations (2)

2901

Alhakeem Radiology Center, Manama

Unknown

King Hamad University Hospital, Al Muharraq

All Listed Sponsors
collaborator

King Hamad University Hospital, Bahrain

OTHER

collaborator

King Faisal Specialist Hospital & Research Center

OTHER

collaborator

King Fahad Medical City

OTHER_GOV

lead

Royal College of Surgeons in Ireland - Medical University of Bahrain

OTHER